Market Outlook
The Saudi Arabia Antiviral Drugs Market was valued at USD 505.15 million in 2024 and is projected to grow at a CAGR of 2.39% through 2030. This growth is driven by increasing prevalence of viral infections such as HIV, hepatitis, and influenza, alongside rising healthcare expenditure and government initiatives to improve healthcare infrastructure. The growing awareness about antiviral treatments and the introduction of advanced therapies are further propelling market expansion. Add